Literature DB >> 26379910

p53 mediated apoptosis in osteosarcoma MG-63 cells by inhibition of FANCD2 gene expression.

Peng Xia1, Yifu Sun2, Changjun Zheng1, Tingting Hou1, Mingyang Kang1, Xiaoyu Yang1.   

Abstract

PURPOSE: The aim of this study was to investigate the association between osteosarcoma (OS) and Fanconi anemia (FA) related pathways and the molecular mechanisms.
METHODS: siRNA for Fanconi anemia complementation group D2 (FANCD2) was constructed and transfected into the osteosarcoma cell line MG-63 cells. Expression of TP53INP1, p53, p21, caspase-9, and caspase-3 mRNA in MG-63 cells were examined by real-time fluorescence quantitative PCR, and the protein levels were also determined by western blot.
RESULTS: After silence of the FANCD2 gene in MG-63 cells, cell proliferation was inhibited, cell cycle was arrested and cell apoptosis was induced. The apoptosis was mediated by the p53 signaling pathway. After FANCD2 expression was inhibited, TP53INP1 gene expression was up-regulated, phosphorylation of p53 was promoted and the p21 protein was activated, leading to cell cycle arrested in G1, finally resulted in caspase-dependent cell apoptosis.
CONCLUSIONS: Inhibition of FANCD2 gene expression can induce apoptosis of osteosarcoma cells, which indicated that FANCD2 played an important role in the development of osteosarcoma and it might be a potential target for treatment of osteosarcoma.

Entities:  

Keywords:  Fanconi anemia complementation group D2; RNA interference; cell apoptosis; osteosarcoma; p53

Year:  2015        PMID: 26379910      PMCID: PMC4565293     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  42 in total

1.  Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.

Authors:  Jan Smida; Daniel Baumhoer; Michael Rosemann; Axel Walch; Stefan Bielack; Christopher Poremba; Klaus Remberger; Eberhard Korsching; Wolfram Scheurlen; Christian Dierkes; Stefan Burdach; Gernot Jundt; Michael J Atkinson; Michaela Nathrath
Journal:  Clin Cancer Res       Date:  2010-07-07       Impact factor: 12.531

2.  A tumor suppressor function for caspase-2.

Authors:  Lien Ha Ho; Robyn Taylor; Loretta Dorstyn; Dimitrios Cakouros; Philippe Bouillet; Sharad Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-11       Impact factor: 11.205

Review 3.  Osteosarcoma: Conventional treatment vs. gene therapy.

Authors:  Mei Lin Tan; Peter F M Choong; Crispin R Dass
Journal:  Cancer Biol Ther       Date:  2009-02-12       Impact factor: 4.742

4.  Pravastatin slows the progression of heart failure by inhibiting the c-Jun N-terminal kinase-mediated intrinsic apoptotic signaling pathway.

Authors:  Shiping Cao; Zhi Zeng; Xianbao Wang; Jianping Bin; Dingli Xu; Yulin Liao
Journal:  Mol Med Rep       Date:  2013-08-09       Impact factor: 2.952

5.  BCCIP suppresses tumor initiation but is required for tumor progression.

Authors:  Yi-Yuan Huang; Li Dai; Dakim Gaines; Roberto Droz-Rosario; Huimei Lu; Jingmei Liu; Zhiyuan Shen
Journal:  Cancer Res       Date:  2013-10-21       Impact factor: 12.701

6.  Executioner caspase-3 and caspase-7 are functionally distinct proteases.

Authors:  John G Walsh; Sean P Cullen; Clare Sheridan; Alexander U Lüthi; Christopher Gerner; Seamus J Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

7.  D-pinitol promotes apoptosis in MCF-7 cells via induction of p53 and Bax and inhibition of Bcl-2 and NF-κB.

Authors:  Thamaraiselvan Rengarajan; Natarajan Nandakumar; Peramaiyan Rajendran; Lingaiah Haribabu; Ikuo Nishigaki; Maruthaiveeran Periyasamy Balasubramanian
Journal:  Asian Pac J Cancer Prev       Date:  2014

Review 8.  Reactivation of p53 as therapeutic intervention for malignant melanoma.

Authors:  Aart G Jochemsen
Journal:  Curr Opin Oncol       Date:  2014-01       Impact factor: 3.645

9.  Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis.

Authors:  M Koptyra; T Stoklosa; G Hoser; E Glodkowska-Mrowka; I Seferynska; A Klejman; J Blasiak; T Skorski
Journal:  Leukemia       Date:  2011-04-26       Impact factor: 11.528

10.  Genomic instability and telomere fusion of canine osteosarcoma cells.

Authors:  Junko Maeda; Charles R Yurkon; Hiroshi Fujisawa; Masami Kaneko; Stefan C Genet; Erica J Roybal; Garrett W Rota; Ethan R Saffer; Barbara J Rose; William H Hanneman; Douglas H Thamm; Takamitsu A Kato
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

View more
  5 in total

1.  Targeting Akt/NF-κB/p53 Pathway and Apoptosis Inducing Potential of 1,2-Benzenedicarboxylic Acid, Bis (2-Methyl Propyl) Ester Isolated from Onosma bracteata Wall. against Human Osteosarcoma (MG-63) Cells.

Authors:  Ajay Kumar; Sandeep Kaur; Sukhvinder Dhiman; Prithvi Pal Singh; Gaurav Bhatia; Sharad Thakur; Hardeep Singh Tuli; Upendra Sharma; Subodh Kumar; Abdulmajeed G Almutary; Abdullah M Alnuqaydan; Arif Hussain; Shafiul Haque; Kuldeep Dhama; Satwinderjeet Kaur
Journal:  Molecules       Date:  2022-05-28       Impact factor: 4.927

2.  Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation.

Authors:  Adriana Carol Eleonora Graziano; Venera Cardile; Rosanna Avola; Nunzio Vicario; Carmela Parenti; Lucia Salvatorelli; Gaetano Magro; Rosalba Parenti
Journal:  Oncotarget       Date:  2017-02-21

3.  Fanconi anemia protein FANCD2 is activated by AICAR, a modulator of AMPK and cellular energy metabolism.

Authors:  Min Jeong Chun; Hana Choi; Dong Wha Jun; Sunshin Kim; Yong-Nyun Kim; Soo-Youl Kim; Chang-Hun Lee
Journal:  FEBS Open Bio       Date:  2017-01-09       Impact factor: 2.693

4.  TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer.

Authors:  Yi Wang; Huizhi Sun; Danfang Zhang; Dan Fan; Yanhui Zhang; Xueyi Dong; Shiqi Liu; Zhao Yang; Chunsheng Ni; Yanlei Li; Fang Liu; Xiulan Zhao
Journal:  J Cell Mol Med       Date:  2018-04-14       Impact factor: 5.310

5.  FANCI and FANCD2 have common as well as independent functions during the cellular replication stress response.

Authors:  Elizabeth L Thompson; Jung E Yeo; Eun-A Lee; Yinan Kan; Maya Raghunandan; Constanze Wiek; Helmut Hanenberg; Orlando D Schärer; Eric A Hendrickson; Alexandra Sobeck
Journal:  Nucleic Acids Res       Date:  2017-11-16       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.